Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ARX vs HTFL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ARX Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

ARX Overall Winner 6-Pillar Tally: ARX 6 – 0 HTFL Matrix Metrics: ARX 8 – 2 HTFL

As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over Heartflow, Inc. (HTFL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas HTFL carries 55.4/100 (HOLD) at $46.86 (N/M Forward P/E, -30.0% operating margin).

  • Composite vs. Pillar Nuance: While HTFL currently prints a higher short-term Unified Composite Score (55.4/100 HOLD vs. ARX 46.9/100 HOLD), ARX captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (3.7% vs. -30.0% operating margin) and revenue trajectory (+6.1% vs. +57.4% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ARX vs HTFL
ARX NYSE Head-to-Head Winner
Accelerant Holdings
Insurance Agents, Brokers & Service
$19.87
+0.1% 1D
Market Cap $4.3B
TTM Revenue $2.79B
Forward P/E 21.3x
Beta / 30D Vol -0.19β · 2% Vol
Unified Composite Score
46.9 / 100 HOLD
Tech 34.0 Fund 50.0 Flow 76.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 70
RSI-14: 69.8 · SMA20: $19.83 · SMA50: $19.80
HTFL NASDAQ
Heartflow, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$46.86
-3.3% 1D
Market Cap $4.3B
TTM Revenue $239M
Forward P/E N/M
Beta / 30D Vol 1.48β · 96% Vol
Unified Composite Score
55.4 / 100 HOLD
Tech 36.0 Fund 54.0 Flow 65.0 Mom 70.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 39
RSI-14: 39.5 · SMA20: $55.68 · SMA50: $51.87

6-Pillar Scorecard Institutional Category Breakdown (ARX 6 – 0 HTFL)

Columns: Metric · ARX · HTFL
1. Valuation Multiples ARX
Forward P/E 21.3x N/M
Trailing P/E 27.6x 72.3x
PEG Ratio N/M N/M
EV / Revenue N/M 17.8x
2. Growth & Scale ARX
Revenue Growth (YoY) +6.1% +57.4%
Earnings Growth (YoY) +800.0% +0.0%
TTM Revenue (USD) $2.79B $239M
Market Cap $4.3B $4.3B
3. Profitability & Quality ARX
Gross Margin 62.8% 81.8%
Operating Margin 3.7% -30.0%
Net Profit Margin 5.6% -33.1%
Return on Equity (ROE) 9.2% -29.4%
4. Balance Sheet & Cash Flow ARX
Cash Generation (TTM) $634M -$59M
Cash Flow Margin 22.7% -24.8%
Net Cash / Leverage $5.13B Net Cash $7.2M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ARX
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 15.7% (3rd %ile) 91.3% (43rd %ile)
Put/Call OI Skew 0.01x (Call-Skewed) 2.19x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat ARX
OpEx & R&D Intensity 59.1% of Rev ($1.65B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance Brokers Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ARX (8) vs HTFL (2)
Institutional Metric ARX HTFL Criterion Row Edge
Market Capitalization
Scale
$4.3B $4.3B Larger Scale ARX
Trailing P/E Ratio
Valuation
27.6x 72.3x Lower Multiple ARX
Forward P/E Ratio
Valuation
21.3x N/M Lower Multiple ARX
Revenue Growth (YoY)
Growth
+6.1% +57.4% Higher Growth HTFL
Operating Margin (TTM)
Profitability
3.7% -30.0% Higher Margin ARX
Net Profit Margin
Profitability
5.6% -33.1% Higher Margin ARX
Return on Equity (ROE)
Capital Efficiency
9.2% -29.4% Higher ROE ARX
52-Week Range Position
Momentum
100% ($9–$20) 66% ($20–$61) Stronger Trend ARX
Beta / 30D Volatility
Risk Regime
-0.19β · 2% Vol 1.48β · 96% Vol Lower Realized Risk ARX
Unified Institutional Score
Composite Signal
46.9 / 100 (HOLD) 55.4 / 100 (HOLD) Higher Composite HTFL
Trailing 12M Revenue (USD)
Operating Scale
$2.79B $239M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
62.8% 81.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 17.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$634M ($5.13B Net Cash) -$59M ($7.2M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ARX +3.57 pp
ARX: +0.61% · HTFL: -2.96%
3M Horizon HTFL +2.02 pp
ARX: +1.58% · HTFL: +3.6%
6M Horizon HTFL +57.84 pp
ARX: +24.89% · HTFL: +82.73%
1Y Horizon HTFL +7.05 pp
ARX: +44.4% · HTFL: +51.45%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period ARX Revenue HTFL Revenue ARX Op. Margin HTFL Op. Margin Margin Leader
FY2023 $340M $90M N/A -83.6% HTFL
FY2024 $600M $130M N/A -48.7% HTFL
FY2025 $910M $180M N/A -36.4% HTFL

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ARX CONSOLIDATION
50d in phase · OBV NEUTRAL
Current IV 15.7%
IV Percentile 3rd %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ARX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HTFL CONSOLIDATION
16d in phase · OBV ACCUMULATION
Current IV 91.3%
IV Percentile 43rd %ile
Put/Call OI Skew 2.19x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow ACCUMULATION
Exact HTFL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ARX Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 3.7% operating margin.
OpEx & R&D Reinvestment 59.1% of Rev ($1.65B)
90D Engineering Disclosures 0 Published
HTFL Moat Profile Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $4.3B market capitalization and -30.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ARX vs HTFL Key Questions & Quantitative Answers

As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over Heartflow, Inc. (HTFL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas HTFL carries 55.4/100 (HOLD) at $46.86 (N/M Forward P/E, -30.0% operating margin). Composite vs. Pillar Nuance: While HTFL currently prints a higher short-term Unified Composite Score (55.4/100 HOLD vs. ARX 46.9/100 HOLD), ARX captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (3.7% vs. -30.0% operating margin) and revenue trajectory (+6.1% vs. +57.4% YoY).

ARX leads the Growth & Scale pillar: ARX posts +6.1% YoY revenue growth and +800.0% YoY earnings growth on $2.79B TTM revenue (62.8% gross margin, 3.7% operating margin), compared with HTFL at +57.4% YoY revenue growth and +0.0% YoY earnings growth on $239M TTM revenue (81.8% gross margin, -30.0% operating margin). Across the 3-period historical trajectory (FY2023 to FY2025), ARX cumulative revenue shifted +167.6% while HTFL shifted +100.0%. In operating R&D and SG&A reinvestment, ARX deploys 59.1% of Rev ($1.65B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HTFL.

ARX screens cheaper on headline valuation multiples. ARX trades at 21.3x Forward P/E, 27.6x Trailing P/E, N/M PEG, and N/M EV/Revenue (22.7% FCF margin), whereas HTFL trades at N/M Forward P/E, 72.3x Trailing P/E, N/M PEG, and 17.8x EV/Revenue (-24.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARX (9.2% ROE) versus HTFL (-29.4% ROE) capital efficiency.

In options market volatility and institutional positioning, ARX carries 15.7% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.19β · 2% Vol realized risk). By comparison, HTFL carries 91.3% implied volatility (43rd %ile, Balanced (25th–60th %ile)), a 2.19x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.48β · 96% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.